UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008567
Receipt number R000010070
Scientific Title Chemopreventive effect of Minodronic acid hydrate for the patients treated with Aromatase inhibitor
Date of disclosure of the study information 2012/10/01
Last modified on 2012/07/30 16:10:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Chemopreventive effect of Minodronic acid hydrate for the patients treated with Aromatase inhibitor

Acronym

Chemopreventive effect of Minodronic acid hydrate for the patients treated with AI

Scientific Title

Chemopreventive effect of Minodronic acid hydrate for the patients treated with Aromatase inhibitor

Scientific Title:Acronym

Chemopreventive effect of Minodronic acid hydrate for the patients treated with AI

Region

Japan


Condition

Condition

Breast Cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Chemopreventive effect of Minodronic acid hydrate

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Efficacy

Key secondary outcomes

safety


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

medication

Interventions/Control_2

unmedication

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

75 years-old >=

Gender

Female

Key inclusion criteria

newly AI started breast cancer patients

Key exclusion criteria

Patients cannot use Minodronic acid hydrate

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Tangoku

Organization

Tokushima University Hospital

Division name

departemnt of esophageal, breast and thyroid diseases

Zip code


Address

2-50-1Kuramotocho, Tokushima city

TEL

088-633-7143

Email



Public contact

Name of contact person

1st name
Middle name
Last name Michi Miki

Organization

The University of Tokushima graduate school

Division name

Department of Thoracic, Endocrine surgery and Oncology

Zip code


Address

Kuramoto 3-18-15

TEL

088-633-7143

Homepage URL


Email

surgery2@clin.med.tokushima-u.ac.jp


Sponsor or person

Institute

The University of Tokushima graduate school

Institute

Department

Personal name



Funding Source

Organization

The University of Tokushima graduate school

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2012 Year 09 Month 15 Day

Date of IRB


Anticipated trial start date

2012 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 07 Month 30 Day

Last modified on

2012 Year 07 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010070


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name